Ablacon, Inc.

📍 Wheat Ridge, United States👥 29 employees💰 Last funded May 2019
Research🌐 ablacon.com
Website LinkedIn
Atrial Fibrillation (AF) is the most frequent arrhythmic disorder of the heart. At Ablacon, we leverage our expertise in electrophysiology, computer vision and deep learning to build a real-time high-precision AI-based diagnosis system. We are an international team based in Lausanne (CH), Denver, CO (US) and Munich (DE) with a partner clinic in Hamburg (DE). If you are looking for the next big challenge, a wonderful team and a purpose that literally saves lives, you might want to consider joining us.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Ablacon, Inc.?
Ablacon, Inc. has 1 investors on record on gritt.io.
When did Ablacon, Inc. last raise funding?
The most recent investment in Ablacon, Inc. recorded on gritt.io was in May 2019.
What industry is Ablacon, Inc. in?
Ablacon, Inc. operates in Research. Find similar Research investors on gritt.io.
Where is Ablacon, Inc. based?
Ablacon, Inc. is headquartered in Wheat Ridge, United States.